Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cansino Biologics Inc
6185Current price
27.50 HKD
+0.65 HKD (+2.42%)
Last closed
55.39 CNY
Company
www.cansinotech.com
ISIN
CNE100004BM0
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Hong Kong Stock Exchange
Capitalization
9 792 869 742 CNY
Yield for 12 month
-13.56 %
1Y
3Y
5Y
10Y
15Y
6185
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China. Address: 401-420, Biomedical Park, Tianjin, China, 300457
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
449.72 CNYP/E ratio
–Dividend Yield
–Current Year
+345 153 751 CNY
Last Year
+1 030 956 630 CNY
Current Quarter
+171 123 716 CNY
Last Quarter
+114 272 928 CNY
Current Year
-875 947 316 CNY
Last Year
-186 591 727 CNY
Current Quarter
+119 091 658 CNY
Last Quarter
+68 044 030 CNY
Key Figures 6185
1 year
3 years
5 years
10 years
EBITDA
-829 665 668 CNY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-7.92 %
PEG Ratio
–
Return On Equity TTM
-13.62 %
Wall Street Target Price
449.72 CNY
Revenue TTM
748 468 219 CNY
Book Value
20.58 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
76.10 %
Dividend Yield
–
Gross Profit TTM
-25 864 541 CNY
Earnings per share
-3.52 CNY
Diluted Eps TTM
-3.52 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-96.20 %
Dividend Analytics 6185
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
-21.00 %Dividend History 6185
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
23.08.2022
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 6185
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
13.80
Price Sales TTM
13.08
Enterprise Value EBITDA
-3.94
Price Book MRQ
2.70
Financials 6185
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 6185
For 52 weeks
37.12 CNY
74.99 CNY
50 Day MA
63.33 CNY
Shares Short Prior Month
–
200 Day MA
50.60 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart